Jeil Pharma Holdings Inc (KRX:002620)

South Korea · Delayed Price · Currency is KRW

8,490.00

-100.00 (-1.16%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Investment Sector			13.69B	11.61B	11.92B	17.03B	15.30B
Investment Sector Growth			17.86%	-2.56%	-30.02%	11.34%	17.10%
Pharmaceutical Sector			818.40B	812.94B	778.72B	773.34B	742.06B
Pharmaceutical Sector Growth			0.67%	4.39%	0.70%	4.22%	453.52%
Consolidated Adjustments			-28.04B	-31.59B	-28.07B	-28.37B	-25.55B
Total			804.04B	792.96B	762.57B	762.00B	731.80B
Total Growth			1.40%	3.99%	0.07%	4.13%	412.70%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			777.17B	786.91B	761.64B	748.51B	713.58B
South Korea Growth			-1.24%	3.32%	1.75%	4.90%	473.10%
Consolidated Adjustments			-28.04B	-31.59B	-30.07B	-28.37B	-25.55B
Overseas			54.92B	37.64B	31.00B	41.86B	43.78B
Overseas Growth			45.90%	21.43%	-25.94%	-4.39%	150.38%

Source: S&P Global Market Intelligence.